NVCR Q2 2025 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

Q2 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$159M+5.6% YoY

Gross Profit

$117M73.9% margin

Operating Income

-$40M-24.9% margin

Net Income

-$40M-25.3% margin

EPS (Diluted)

$-0.36

QoQ Revenue Growth

+2.5%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$21M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$896M

Stockholders' Equity

$349M

Cash & Equivalents

$150M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$159M	$150M	+5.6%
Gross Profit	$117M	$116M	+1.4%
Operating Income	-$40M	-$34M	-17.6%
Net Income	-$40M	-$33M	-20.3%

Geographic Segments

UNITED STATES

$94M46%

International Markets

$60M29%

GERMANY

$19M9%

FRANCE

$18M9%

JAPAN

$9M5%

CHINA

$5M2%